Bipolar I Depression Clinical Trial
Official title:
A Randomized, 6-Week, Double-blind, Placebo-Controlled, Flexible Dose, Parallel-Group Study to Evaluate the Efficacy and Safety of Lurasidone in Children and Adolescent Subjects With Bipolar I Depression
A study to evaluate efficacy and safety of flexibly dosed Lurasidone in children and adolescents with bipolar I depression
This is a randomized, parallel, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of flexibly dosed lurasidone (20 - 80 mg/day) for 6 weeks compared with placebo in children and adolescent subjects with depression associated with Bipolar I Disorder (bipolar depression). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00812058 -
A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression
|
Phase 2 | |
| Completed |
NCT00481195 -
Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
|
Phase 2 | |
| Completed |
NCT01403662 -
Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression
|
Phase 3 | |
| Recruiting |
NCT03336918 -
Lithium Effects on the Brain's Functional and Structural Connectome in the Treatment of Bipolar Disorder
|
||
| Terminated |
NCT04383691 -
A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression
|
Phase 3 |